
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $164.8M | -- | -- | $1.19 | -- |
07/29/2025 | Q2 | $161.1M | -- | -- | $1.12 | -- |
04/28/2025 | Q1 | $169M | $145.1M | $0.93 | $1.28 | -$0.35 |
01/28/2025 | Q4 | $158.8M | $193.1M | $1.85 | $1.30 | $0.55 |
10/28/2024 | Q3 | $159.7M | $148.4M | $1.17 | $1.42 | -$0.25 |
07/29/2024 | Q2 | $160.7M | $158.5M | $1.49 | $1.57 | -$0.08 |
04/29/2024 | Q1 | $144.2M | $167M | $1.80 | $1.38 | $0.42 |
01/29/2024 | Q4 | $142.7M | $158.1M | $1.58 | $1.44 | $0.14 |
10/26/2023 | Q3 | -- | -- | $1.68 | $1.32 | $0.36 |
07/27/2023 | Q2 | -- | -- | $1.31 | $1.23 | $0.08 |
04/27/2023 | Q1 | -- | -- | $1.07 | $1.13 | -$0.06 |
01/30/2023 | Q4 | -- | -- | $1.12 | $1.07 | $0.06 |
10/27/2022 | Q3 | -- | -- | $1.22 | $1.22 | -- |
07/28/2022 | Q2 | -- | -- | $1.11 | $0.90 | $0.21 |
04/28/2022 | Q1 | -- | -- | $1.02 | -- | -- |
01/31/2022 | Q4 | -- | -- | $1.14 | -- | -- |
10/28/2021 | Q3 | -- | -- | $1.22 | -- | -- |
07/28/2021 | Q2 | -- | -- | $1.06 | -- | -- |
05/10/2021 | Q1 | -- | -- | $1.35 | -- | -- |
01/28/2021 | Q4 | -- | -- | $1.30 | -- | -- |
10/28/2020 | Q3 | -- | -- | $1.19 | -- | -- |
07/28/2020 | Q2 | -- | -- | $0.87 | -- | -- |
04/23/2020 | Q1 | -- | -- | $0.49 | -- | -- |
01/30/2020 | Q4 | -- | -- | $0.61 | -- | -- |
10/30/2019 | Q3 | -- | -- | $0.40 | -- | -- |
07/30/2019 | Q2 | -- | -- | $0.34 | -- | -- |
04/30/2019 | Q1 | -- | -- | $0.23 | -- | -- |
01/30/2019 | Q4 | -- | -- | $0.34 | -- | -- |
10/30/2018 | Q3 | -- | -- | $0.37 | -- | -- |
07/30/2018 | Q2 | -- | -- | $0.35 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.33 | -- | -- |
02/08/2018 | Q4 | -- | -- | $0.49 | -- | -- |
12/07/2017 | Q3 | -- | -- | $0.24 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.44 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.26 | -- | -- |
12/31/2016 | Q4 | -- | -- | $0.25 | -- | -- |
09/30/2016 | Q3 | -- | -- | $0.34 | -- | -- |
Merchants Bancorp reported $145.1M worth of top line sales in its most recent quarter.
Merchants Bancorp announced earnings per share of $0.93 which represents a miss of analyst forecast a $1.28 per share.
Merchants Bancorp reported -- that represents -- per share over the last quarter.
Merchants Bancorp's earnings are forecast to decrease from $6.30 per share to $5.79 per share next year representing a decrease of -27.73%.
Merchants Bancorp's next earnings date is July 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.